Pharmatech
Pharmatech operates oncology clinical trial management and molecular profiling services, running the Right-In-Time network of 610+ locations and 2,200+ investigators to match cancer patients to biopharma-sponsored trials via AI-enhanced molecular testing and trial-matching platforms.
- Company typePrivate
- Founded2008
- HeadquartersDenver, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Pharmatech does
Pharmatech operates as a clinical research management and site management organization (SMO) in the pharmaceuticals space, with a deeply embedded operational profile centered on oncology clinical trial execution and molecular profiling. The company runs the Right-In-Time (RIT) clinical trial network, which spans more than 610 locations across the United States and Puerto Rico and is staffed by 2,200+ trial investigators. Through this network, the company reports identifying more than 71,000 patients and maintaining active relationships with 110+ biopharmaceutical companies and 30+ active clinical trials. The core capability is rapid patient-trial matching, with reported enrollment timelines of approximately two weeks and as little as five days, materially shorter than industry-standard oncology trial startup cycles.
The product portfolio includes tissue-based molecular profiling tests (MI Cancer Seek, MI Clarity, MI Profile, MI Tumor Seek Hybrid), blood-based tests (Caris Assure, Caris ChromoSeq), AI-powered therapy guidance signatures (Caris GPSai, Caris FOLFIRSTai), and supporting platforms including TrialPlus for on-demand clinical trial searching, Caris CODEai and Nanoverse for AI-driven cancer outcome research, the Caris Molecular Tumor Board for expert interpretation, and the Caris Precision Oncology Alliance (POA) for physician community engagement. Clinical Trial Navigators (CTNs), described as specially trained registered nurses, execute the matching workflow from biomarker result to trial enrollment. Underlying the platform is multimodal AI processing of structured molecular data (genomic, transcriptomic, proteomic) combined with text-based clinical trial protocols.
The business model spans two primary revenue streams: (1) molecular profiling and AI signature services sold to oncology physicians and patients via a physician portal (portal.caris.ai) and direct online ordering (order.carislifesciences.com), with international distribution outside the United States, and (2) clinical trial matching, site activation, and biopharma services sold to pharmaceutical sponsors seeking decentralized trial execution. Pricing is not publicly disclosed. A June 2026 announcement of a dual listing on NYSE Texas alongside a share repurchase program indicates a transition toward public-market capitalization, though the underlying corporate status in source material is listed as private. Note: the firmographic record for Pharmatech (founded 1987, 11-50 employees, Denver) is inconsistent with the much larger operational scale described in the supporting data (610+ locations, 2,200+ investigators), suggesting either a corporate restructuring, a subsidiary/parent relationship, or a data consolidation artifact that materially affects interpretation of this profile.
Pharmatech firmographics
Firmographics- Name
- Pharmatech
- Legal name
- Caris Life Sciences
- Website
- https://pharmatech.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharmatech operates oncology clinical trial management and molecular profiling services, running the Right-In-Time network of 610+ locations and 2,200+ investigators to match cancer patients to biopharma-sponsored trials via AI-enhanced molecular testing and trial-matching platforms.
- Ownership category
- akta.pro rank
Pharmatech industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
- akta.pro secondary industry
- Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
Keywords
Where Pharmatech is headquartered
LocationHeadquarters
- HQ city
- Denver
- HQ country
- United States
- HQ region
- North America
Markets served
Pharmatech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Distribution channels4 records
Marketing channels4 records
Pharmatech product offering
Product offeringCore offering
Pharmatech is a pharmaceuticals company providing clinical research management and SMO (Site Management Organization) services, supporting biopharma sponsors, research facilities, and oncology patients through a clinical trial network.
Product overview
Caris Life Sciences is a molecular profiling company offering AI-enhanced comprehensive molecular testing for cancer diagnosis and treatment. Their portfolio includes tissue-based tests (MI Cancer Seek, MI Clarity, MI Profile, MI Tumor Seek Hybrid), blood-based tests (Caris Assure, Caris ChromoSeq), and AI signature products (Caris GPSai, Caris FOLFIRSTai). The company operates the Right-In-Time (RIT) clinical trial network, a research system designed to rapidly match patients to clinical trials based on molecular profiling results, supported by Clinical Trial Navigators (CTNs) and the TrialPlus platform. Additional services include the Caris Molecular Tumor Board for expert consultation, and biopharma offerings including Caris Discovery and Multimodal Data platforms.
Differentiator
Problem solved
Functional benefit
Brands
- MI Profile: Comprehensive molecular profiling service for tumor analysis
- MI Cancer Seek
- MI Clarity
- MI Tumor Seek Hybrid
- Caris Assure
- Caris ChromoSeq
- Caris GPSai
- Caris FOLFIRSTai
- Right-In-Time (RIT) Trials
- TrialPlus
- Caris CODEai
- Nanoverse
- Caris Molecular Tumor Board
- Caris POA
- Caris POA Fellows Forum
Products and services
- Clinical Research Management and SMO Services
- Oncology Clinical Trial Network
Quantifiable outcome
- Trial enrollment in approximately 2 weeks, and as little as 5 days
- +2 more outcomes
Companies that use Pharmatech
Customer profileSegments4 records
Ideal customer profiles2 records
Pharmatech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Pharmatech partnerships and signals
Strategic signalScale indicators6 records
Recent moves3 records
Expansion highlights6 records
Pharmatech competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Largest global CRO and life sciences technology provider with extensive SMO/site-management capabilities. Comparable because it competes for the same oncology biopharma trial sponsors and offers overlapping site activation, patient recruitment, and decentralized trial services.
- ICON plc: Global CRO with deep oncology and site-management offerings post-PRA acquisition. Comparable because it operates site networks for biopharma sponsors and competes head-to-head for oncology trial site activation and patient enrollment work.
- Labcorp Drug Development (Covance): Large CRO providing clinical development and central laboratory services across therapeutic areas including oncology. Comparable because it offers site management, trial monitoring, and biopharma trial execution services to the same sponsor base.
- PPD (Thermo Fisher Scientific): Global CRO owned by Thermo Fisher Scientific with strong oncology trial execution capabilities. Comparable because it competes for biopharma oncology trials and operates global investigator/site networks.
- Syneos Health: Now-private global CRO with biopharma clinical development and site-management services. Comparable because it manages investigator site networks and patient recruitment for oncology and other therapeutic trials.
Direct peers
- Medpace: Mid-to-large CRO with strong oncology franchise and full-service clinical trial execution. Comparable because it directly competes for biopharma oncology sponsors and operates dedicated investigator site relationships and patient recruitment capabilities.
- Worldwide Clinical Trials: Mid-sized CRO with significant oncology and rare disease focus, offering site management, patient recruitment, and trial monitoring. Comparable because it serves a similar biopharma sponsor base with full-service clinical research management.
- Emmes Group: Privately held clinical research organization with site management and biopharma trial execution capabilities, recently recapitalized. Comparable because it operates as a privately held CRO/SMO serving biopharma sponsors with clinical research management services.
Emerging players
- Clinipace Worldwide (Powered by DZS Clinical): Smaller mid-market CRO with oncology and therapeutic trial management focus. Comparable because it provides clinical trial management and site services to biopharma sponsors in a similar size segment.
Others
- Caris Life Sciences: Precision oncology molecular profiling and AI-driven clinical trial matching platform referenced alongside Pharmatech's Right-In-Time network. Listed as a relevant ecosystem participant / enabling partner rather than a direct SMO competitor, given its diagnostic and data focus versus Pharmatech's site-management focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Pharmatech social profiles
Digital presencePharmatech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmatech leadership team
Management profileNumber of profiles
Profiles1 record
Pharmatech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmatech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmatech
What does Pharmatech do?
Pharmatech is a pharmaceuticals company providing clinical research management and SMO (Site Management Organization) services, supporting biopharma sponsors, research facilities, and oncology patients through a clinical trial network.
Is Pharmatech a public or private company?
Pharmatech is a private company. It is classified as unknown and is currently operating.
When was Pharmatech founded?
Pharmatech was founded in 2008. It employs 11 to 50 people.
Where is Pharmatech based?
Pharmatech is headquartered in Denver, United States, in the North America region.
Who are Pharmatech's main competitors?
Broad incumbents on record are IQVIA, ICON plc, Labcorp Drug Development (Covance), PPD (Thermo Fisher Scientific) and Syneos Health. Direct peers are Medpace, Worldwide Clinical Trials and Emmes Group. Clinipace Worldwide (Powered by DZS Clinical) is listed as an emerging player. Caris Life Sciences is listed as an others.
Does Pharmatech have an API?
No public API is recorded for Pharmatech.
What industry is Pharmatech in?
Pharmatech's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote), with a secondary code of HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts). Its NAICS code is 5417 and its SIC code is 8731.